3.1.2021 Urology COViD Didactics - Genomics of Bladder Cancer
2.22.2021 Urology COViD Didactics - Immunotherapy for Bladder Cancer
4.17.2020 Urology COViD Didactics - BCG Unresponsive Bladder Cancer
Neoadjuvant Immune Checkpoint Inhibition for Muscle Invasive Bladder Cancer
Management of Non Muscle Invasive Bladder Cancer Webcast (2021)
2021 West Oncology | Genitourinary Cancers | Latest Updates on Advanced Bladder Cancer
Novel Therapies to Non Muscle Invasive Bladder Cancer
Focus on Bladder Genetics
Urowebinar: Is immune therapy changing the way we think about early bladder cancer?
Treatment of high risk nMIBC in era of BCG shortage - EMPIRE Urology Lecture Series
UROwebinar: Bladder neoplasms: Will a morphological classification become obsolete?
Dr. Meeks on the Genomics of Bladder Cancer
Immunotherapy for NMIBC: Emerging and Expanding Indications
Dr. Iyer on Advice for Physicians Using Immunotherapy in Bladder Cancer
NCIS ISOS 2021 - Challenges and New Options in the Management of Non-Muscle Invasive Bladder Cancer
Bladder Cancer: The Common Man Meets the Lethal Woman
Beyond BCG in non-muscle invasive Bladder Cancer
Management of BCG-refractory NMIBC w/ Dr. Timothy Clinton & Dr. Eugene Pietzak | BackTable Ep. 64
Examining the State of the Science on New Therapies in Bladder Cancer
Early RC in high risk NMIBC: Is it justified? by Shahrokh SHARIAT
